Personalized treatment of uveal melanoma

被引:48
作者
Damato, B. [1 ]
Heimann, H. [1 ]
机构
[1] Royal Liverpool Univ Hosp, Ocular Oncol Serv, Dept Mol & Clin Canc Med, Liverpool L7 8XP, Merseyside, England
关键词
uveal melanoma; treatment; melanoma; PROTON-BEAM RADIOTHERAPY; CHOROIDAL MELANOMA; TUMOR-CONTROL; ENDORESECTION; BRACHYTHERAPY; PROGNOSIS;
D O I
10.1038/eye.2012.242
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Personalized treatment of uveal melanoma involves the tailoring of all aspects of care to the condition, needs, wishes, and fears of the patient, taking account of the individual's circumstances. When selecting between radiotherapy, surgical resection, and phototherapy, or when deciding how best to combine these different therapeutic modalities, it is necessary to understand the patients utilities, with respect to tumour control, visual conservation, and preservation of the eye, so as to prioritize outcomes accordingly. For example, such considerations would influence the width of the safety margins when administering radiotherapy, according to whether the patient considers it more important to conserve vision or to guarantee tumour control. With 'suspicious naevi', the choice between observation, immediate treatment, and biopsy is complicated by the lack of adequate survival data on which to base rational decisions, making it necessary for both patient and doctor to accept uncertainty. Personalized care should involve close relatives, as appropriate. It must also adapt to changes in the patient's needs over time. Such personalized care demands the ability to respond to such needs and the sensitivity to identify these requirements in the first place. Personalized treatment enhances not only the patient's satisfaction but also the 'job satisfaction' of all members of the multidisciplinary team, improving quality of care. Eye (2013) 27, 172-179; doi:10.1038/eye.2012.242; published online 23 November 2012
引用
收藏
页码:172 / 179
页数:8
相关论文
共 29 条
[1]   Taping outpatient consultations: a survey of attitudes and responses of adult patients with ocular malignancy [J].
Ah-Fat, FG ;
Sharma, MC ;
Damato, BE .
EYE, 1998, 12 (5) :789-791
[2]  
Bridson JD, 2009, CLIN ETHICS, V5, P86
[3]   Sudden Growth of a Choroidal Melanoma and Multiplex Ligation-Dependent Probe Amplification Findings Suggesting Late Transformation to Monosomy 3 Type [J].
Callejo, Sonia A. ;
Dopierala, Justyna ;
Coupland, Sarah E. ;
Damato, Bertil .
ARCHIVES OF OPHTHALMOLOGY, 2011, 129 (07) :958-960
[4]   Psychological aspects of cytogenetic testing of uveal melanoma: preliminary findings and directions for future research [J].
Cook, S. A. ;
Damato, B. ;
Marshall, E. ;
Salmon, P. .
EYE, 2009, 23 (03) :581-585
[5]   Reconciling the principle of patient autonomy with the practice of informed consent: decision-making about prognostication in uveal melanoma [J].
Cook, Sharon A. ;
Damato, Bertil ;
Marshall, Ernie ;
Salmon, Peter .
HEALTH EXPECTATIONS, 2011, 14 (04) :383-396
[6]   Local tumor control after 106Ru brachytherapy of choroidal melanoma [J].
Damato, B ;
Patel, I ;
Campbell, IR ;
Mayles, HM ;
Errington, RD .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02) :385-391
[7]   Visual acuity after Ruthenium106 brachytherapy of choroidal melanomas [J].
Damato, B ;
Patel, I ;
Campbell, IR ;
Mayles, HM ;
Errington, RD .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02) :392-400
[8]   Proton beam radiotherapy of iris melanoma [J].
Damato, B ;
Kacperek, A ;
Chopra, M ;
Sheen, MA ;
Campbell, IR ;
Errington, RD .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (01) :109-115
[9]   Proton beam radiotherapy of choroidal melanoma: The Liverpool-Clatterbridge experience [J].
Damato, B ;
Kacperek, A ;
Chopra, M ;
Campbell, IR ;
Errington, RD .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 62 (05) :1405-1411
[10]   Conservation of eyes with choroidal melanoma by a multimodality approach to treatment - An audit of 1632 patients [J].
Damato, B ;
Lecuona, K .
OPHTHALMOLOGY, 2004, 111 (05) :977-983